# GLOW

> A three-peptide skin-and-recovery blend typically combining GHK-Cu, BPC-157, and TB-500.

- Also known as: GLOW blend, GHK-Cu + BPC-157 + TB-500
- Class: Cosmetic, Healing & Repair
- FDA approved: No
- Canonical page: https://americanpeptide.com/catalog/glow

## Overview

GLOW is a marketed blend that typically combines the copper tripeptide GHK-Cu with BPC-157 and TB-500 — pairing a skin-and-collagen peptide with the two most-studied tissue-repair peptides. It is positioned around skin quality and recovery. Exact components and ratios are defined by the vendor and are not standardized, and no controlled study has tested the mixture; the components are each research compounds studied individually.

GLOW sits at the overlap of the cosmetic and repair literatures: GHK-Cu is studied for collagen synthesis, matrix remodeling, and skin appearance, while BPC-157 and TB-500 are the recovery peptides it is usually bundled with. The name reflects the skin-quality framing, and the blend is marketed as a single convenience vial.

As with any blend, the combined formulation has no trial behind it, and vendor formulas differ — the GHK-Cu-plus-BPC-157-plus-TB-500 recipe is the common one but not a specification. Treat the composition as vendor-defined. None of the components is FDA-approved, and this is a research reference rather than a cosmetic or medical recommendation.

## Mechanism

GHK-Cu: copper delivery, collagen and extracellular-matrix gene regulation, antioxidant signaling. BPC-157 and TB-500: angiogenesis and actin-driven cell migration (see their pages). Combined effect is proposed, not measured.

## Research areas

Studied in: Skin and collagen research, Soft-tissue repair (preclinical), Cosmetic peptide research.

Guides on this site:

- [Wound Healing & Tissue Repair](https://americanpeptide.com/research-areas/wound-healing): Regenerative peptides studied for soft-tissue, tendon, and vascular repair.

## Key research

- Skin + repair overlap — combines a collagen/matrix peptide (GHK-Cu) with two repair peptides (BPC-157, TB-500).
- Vendor-defined recipe — the three-peptide composition is common but not standardized across suppliers.
- No combined study — the blend itself is untested in controlled research; evidence is per-component.
- Not FDA-approved — a research blend, not an approved product.

## Storage, handling & synthesis

**Storage.** Store lyophilized, frozen, and protected from light; after reconstitution keep refrigerated and use quickly. Copper-containing peptides are light- and oxidation-sensitive, so the GHK-Cu component sets much of the handling.

**Handling.** Reconstitute gently without vortexing and protect from light. Read any certificate as three separate assays plus copper content, not one blended purity figure.

**Synthesis.** A physical mixture of three separately made compounds — GHK-Cu (a copper-complexed tripeptide), BPC-157, and TB-500 — so there is no single synthesis or purity number. A meaningful certificate assays each component on its own, states the amount of each, and for the GHK-Cu portion confirms copper content. The more components share a vial, the more the blend’s real-world stability departs from anything characterized.

## FAQs

### What is in the GLOW blend?

It typically combines GHK-Cu, BPC-157, and TB-500, though exact components and ratios are set by the vendor and are not standardized.

### What is it marketed for?

Skin quality and recovery — pairing a collagen/skin peptide (GHK-Cu) with two tissue-repair peptides. These are research framings, not proven outcomes.

### How is it different from KLOW?

KLOW is generally the same idea with a fourth component (KPV) added; GLOW is the three-peptide version. Vendor formulas vary.

### Is it approved?

No — the components are research compounds and the blend is not FDA-approved. This page is a research and educational reference.

## Latest research

Recent trials and publications mentioning GLOW blend, pulled automatically from ClinicalTrials.gov and PubMed (unfiltered search results, refreshed daily).

### Recent trials

- [Barriers and Enablers to Accessing Medical Care for Urinary Incontinence and Prolapse in GLobal Majority Women](https://clinicaltrials.gov/study/NCT07310121) — NOT_YET_RECRUITING · NCT07310121
- [See the Impact Beem's Blue Light Therapy Has on Your Skin Health!](https://clinicaltrials.gov/study/NCT07298382) — RECRUITING · NA · NCT07298382
- [Safety and Efficacy Study of Vasu Facial Beauty Oil](https://clinicaltrials.gov/study/NCT05646953) — COMPLETED · NA · NCT05646953

---

Source: AmericanPeptide.com — https://americanpeptide.com/catalog/glow
Data license: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Attribution: AmericanPeptide.com.
Research reference only — computational and educational content, not medical advice.